Literature DB >> 16866911

Cholesterol as a risk factor for Alzheimer's disease - epidemiological evidence.

M Kivipelto1, A Solomon.   

Abstract

Although dementia is usually a late-life syndrome, it is now well known that pathological changes begin quite early in adulthood, outside the classical age borders of geriatric specialties. In order to design effective preventive strategies, adequate information can only be gathered by taking a life-long view of Alzheimer's disease (AD). Dementia risk is the result of exposure to both harmful and protective factors along the life course, and these factors, as well as their impact on the individual's health status, change over time. This review aims at presenting current epidemiological data on serum cholesterol levels and dietary fat intake as risk factors for dementia/AD, and at discussing the reasons and significance of contradictions between various studies. Reducing dementia risk may be possible by influencing the serum lipid profile. A more detailed characterization of the mechanisms behind the association of cholesterol (in both serum and brain) with dementia/AD, mechanisms about which little is currently known, would allow a better translation of research findings into clinical practice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16866911     DOI: 10.1111/j.1600-0404.2006.00685.x

Source DB:  PubMed          Journal:  Acta Neurol Scand Suppl        ISSN: 0065-1427


  48 in total

1.  Coronary risk correlates with cerebral amyloid deposition.

Authors:  Bruce R Reed; Natalie L Marchant; William J Jagust; Charles C DeCarli; Wendy Mack; Helena C Chui
Journal:  Neurobiol Aging       Date:  2011-11-10       Impact factor: 4.673

2.  Association of Early-Onset Alzheimer Disease With Elevated Low-Density Lipoprotein Cholesterol Levels and Rare Genetic Coding Variants of APOB.

Authors:  Thomas S Wingo; David J Cutler; Aliza P Wingo; Ngoc-Anh Le; Gil D Rabinovici; Bruce L Miller; James J Lah; Allan I Levey
Journal:  JAMA Neurol       Date:  2019-07-01       Impact factor: 18.302

3.  Low HDL cholesterol is a risk factor for deficit and decline in memory in midlife: the Whitehall II study.

Authors:  Archana Singh-Manoux; David Gimeno; Mika Kivimaki; Eric Brunner; Michael G Marmot
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-06-30       Impact factor: 8.311

4.  Association between Cholesterol Exposure and Neuropathological Findings: The ACT Study.

Authors:  Brianne M Bettcher; M Colin Ard; Bruce R Reed; Andreana Benitez; Amanda Simmons; Eric B Larson; Josh A Sonnen; Thomas J Montine; Ge Li; C Dirk Keene; Paul K Crane; Dan Mungas
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Cholesterol Metabolism in Neurodegenerative Diseases: Molecular Mechanisms and Therapeutic Targets.

Authors:  Lijun Dai; Li Zou; Lanxia Meng; Guifen Qiang; Mingmin Yan; Zhentao Zhang
Journal:  Mol Neurobiol       Date:  2021-01-07       Impact factor: 5.590

Review 6.  The vascular contribution to Alzheimer's disease.

Authors:  Robin Altman; John C Rutledge
Journal:  Clin Sci (Lond)       Date:  2010-08-05       Impact factor: 6.124

7.  Cholesterol-related genetic risk scores are associated with hypometabolism in Alzheimer's-affected brain regions.

Authors:  Eric M Reiman; Kewei Chen; Richard J Caselli; Gene E Alexander; Daniel Bandy; Jennifer L Adamson; Wendy Lee; Ashley Cannon; Elizabeth A Stephan; Dietrich A Stephan; Andreas Papassotiropoulos
Journal:  Neuroimage       Date:  2008-01-17       Impact factor: 6.556

8.  The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells.

Authors:  Bhanu Dasari; Jaya R P Prasanthi; Gurdeep Marwarha; Brij B Singh; Othman Ghribi
Journal:  BMC Ophthalmol       Date:  2010-09-13       Impact factor: 2.209

9.  Dementia in Swedish twins: predicting incident cases.

Authors:  Margaret Gatz; Chandra A Reynolds; Deborah Finkel; Nancy L Pedersen; Ellen Walters
Journal:  Behav Genet       Date:  2010-10-24       Impact factor: 2.805

Review 10.  Drug development for Alzheimer's disease: where are we now and where are we headed?

Authors:  Marwan N Sabbagh
Journal:  Am J Geriatr Pharmacother       Date:  2009-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.